Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE
- Institution
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY
- Principal investigator
- Meggan Mackay
- Funding
- $845K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
Abstract – Project 2 The overall goals of Project 2 are to localize and quantify patterns of central nervous system (CNS) dysfunction in SLE patients in long-term clinical remission (SLE-R) and to identify a relevant imaging marker. This has important potential treatment implications as our preliminary data suggest that, despite clinical quiescence, some SLE-R have ongoing CNS dysfunction that may promote progressive cognitive decline and contribute to relapse. Our Specific Aims are: 1. to investigate regional brain metabolism using FDG PET, blood brain barrier permeability (BBBP) using dynamic contrast enhanced MRI (DCE MRI), neuropsychological (NP) performance and serum Quinolinic/Kynurenic acid ratio (Q/K; a marker of CNS pathology) in SLE-R, 2. to investigate microglial (MG) activation in SLE-R using [11C]-PBR28 PET, and 3. to identify and validate a SLE-R functional brain network using resting state functional MRI (rs-fMRI) and to evaluate associations between the SLE-R network and NP performance, Q/K ratios and risk of relapse. A subgroup of eligible subjects from Project 1, 60 SLE-R, 20 SLE with active disease (SLE-A) and 31 healthy controls (HC), will all have imaging studies, NP testing and serum Q/K evaluated at baseline. SLE-R subjects will have repeat evaluations after 18-24 months and/or at the time of clinical relapse. CNS subjects will be recruited at all sites, reflecting significant geographic, ethnic and racial diversity. The planned analyses will allow us to develop neurophenotypes, defined by imaging measures, Q/K ratio and NP performance, for SLE-R. We expect to identify a range of neurophenotypes among SLE-R; some SLE-R will resemble HC, others will resemble SLE-A and perhaps others will have a phenotype that correlates with relapse. In collaboration with the Biostatistics and Data Integration Core we will further explore the heterogeneity among SLE-R neurophenotypes and associations with the immune phenotypes identified in Project 1.
LOADING MOONBASE SCORE
Questions for FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE
Meggan Mackay · $91K · 2025–2029
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE
Meggan Mackay · $133K · 2025–2029
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Assessing Brain Dysfunction in Individuals with SLE: Heterogeneity, Mechanisms and Metrics
Meggan Mackay · $573K · 2008–2030